Belgium: drug-related information and data
Belgium
Our partner in Belgium
Rue Juliette Wytsman 14
B-1050 Bruxelles/Brussels
Tel. +32 26425034
Fax +32 26425749
Head of focal point: Mr Johan Van Bussel
The Belgian focal point is located within the Epidemiology Unit of the Scientific Institute of Public Health (IPH). The IPH is a state (federal) scientific organisation under the responsibility of the Federal Public Service of Public Health, Food Chain Safety and Environment. The main tasks of the drugs programme of the IPH include the monitoring, collection, analysis and dissemination of drug-related information. It also maintains an early warning system on synthetic drugs.E-mail addresses have been inserted in a way discouraging spam. Please replace [a] by @ before actually using any of the e-mail addresses.
Country situation summaries are written with the general reader in mind and provide short, mainly text-based analyses of national drug situations.
Key data sheets provide an at-a-glance statistical view of the drug situation by country and cover areas including prevalence, problem drug use, infectious diseases, deaths, and more.
Country barometers provide a graphical representation of drug use prevalence data for each country, showing its position relative to other countries by population and drug.
What are countries in Europe doing to prevent illicit drug use? 'Prevention profiles' attempts to answer this question using interactive maps and data charts based on expert appraisals.
Legal profiles describe national drug-related legislation in a standardised, comparable format. Topics covered include possession, trafficking, classification, prosecution, prevention, treatment, among others.
This resource provides access to the current national strategies and action plans for each country as well as a brief description of recent and ongoing work in the area.
Each treatment profile provides information on the national context, treatment registries and monitoring systems, treatment demand, availability of treatment services as well as references and resources.
Each overview describes: the national context; references and resources; key responses for preventing and reducing drug-related infectious diseases and; drug-related deaths and drug-related harms in recreational settings.
These data sheets on drug-related public expenditure cover 30 countries and examine how much countries spend on drug-related activities, whether there are specific budgets allocated to drug policy documents, and how drug-related expenditure has evolved over time.
National reports draw an overall picture of the drug phenomenon at national level. The data is an important resource, among others for the compilation of the EMCDDA's Annual report.
National drug related research provides information by country in the following areas: main funding frameworks, research institutions, scientific journals, websites, main studies conducted and articles published.
